Internal Medicine News - Zidovudine Capsules
May 15, 2006 -- Zidovudine Capsules (zidovudine, Aurobindo Pharma) The first generic capsule formulation of the nucleoside reverse transcriptase inhibitor...
Research Initiative/Treatment Action! - ZIDOVUDINE
March 1, 2000 -- Zidovudine is supplied most commonly in film-coated tablets (300 mg, biconvex, round and white) with "GXCW3" on one side and...
Skin & Allergy News - Relenza, generic zidovudine
June 1, 2006 -- Relenza (zanamivir for GlaxoSmithKline) An antiviral for prophylaxis of influenza in adults and children aged 5 years and older. Previously...
Internal Medicine News - Zidovudine hyperpigmentation mainly in blacks
November 1, 2004 -- SAN DIEGO -- Fewer than 1% of 12,635 HIV-infected patients on antiretroviral therapy developed hyperpigmentation skin disorders, which occurred more...
Chain Drug Review - FDA O.K.'s capsule form of generic zidovudine
May 1, 2006 -- WASHINGTON -- The Food and Drug Administration has issued the first approval for a generic capsule version of the HIV/AIDS drug zidovudine to be...
Journal of AOAC International - Quantitative determination and sampling of lamivudine and zidovudine residues for cleaning validation in a production area
May 1, 2007 -- Lamivudine (3TC) and zidovudine (AZT) are systemic antiviral substances extensively used in human immunodeficiency virus (HIV) infected patients....
Business Wire - Research and Markets: Generics Company Cipla Claims to Have Been the First Local Manufacturer to Introduce a Number of Products to the Indian Market, Including...
May 19, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c45980) has announced the addition of Cipla Generics Company...
M2 Presswire - Generics Company Cipla Claims To Have Been the First Local Manufacturer to Introduce a Number of Products to the Indian Market, Including the Antiretrovirals...
May 18, 2007 -- M2 PRESSWIRE-18 May 2007-Research and Markets: Generics Company Cipla Claims To Have Been the First Local Manufacturer to Introduce a Number of...
M2 Presswire - FDA tentatively approves generic zidovudine oral solution, for HIV/AIDS; Treatment in association with the Presidents Emergency Plan for AIDS relief.
September 9, 2005 -- M2 PRESSWIRE-9 September 2005-US FDA: FDA tentatively approves generic zidovudine oral solution, for HIV/AIDS; Treatment in association with the...
Business Wire - Pfizer's Novel HIV/AIDS Treatment Selzentry™ Demonstrates Increased Efficacy Rate In Treatment-Naive HIV Patients
October 26, 2008 -- Results from MERIT ES Data Reanalysis Using Enhanced Sensitivity Tropism Test at 48 Weeks NEW YORK -- Patients taking Selzentry, in combination...
